Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sinusitis | 45 | 2023 | 991 | 7.170 |
Why?
|
Endoscopy | 62 | 2024 | 1851 | 7.060 |
Why?
|
Rhinitis | 30 | 2023 | 747 | 6.340 |
Why?
|
Paranasal Sinuses | 15 | 2021 | 265 | 3.900 |
Why?
|
Dacryocystorhinostomy | 10 | 2024 | 78 | 3.720 |
Why?
|
Nasal Polyps | 16 | 2022 | 395 | 3.500 |
Why?
|
Frontal Sinus | 8 | 2017 | 51 | 2.200 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 12 | 2015 | 324 | 2.180 |
Why?
|
Decompression, Surgical | 10 | 2024 | 606 | 2.030 |
Why?
|
Paranasal Sinus Diseases | 8 | 2020 | 121 | 1.850 |
Why?
|
Lacrimal Duct Obstruction | 5 | 2024 | 53 | 1.680 |
Why?
|
Natural Orifice Endoscopic Surgery | 4 | 2019 | 119 | 1.620 |
Why?
|
Frontal Sinusitis | 8 | 2013 | 19 | 1.610 |
Why?
|
Graves Ophthalmopathy | 7 | 2024 | 133 | 1.520 |
Why?
|
Lacrimal Apparatus Diseases | 2 | 2024 | 72 | 1.480 |
Why?
|
Orbit | 12 | 2024 | 457 | 1.360 |
Why?
|
Chronic Disease | 44 | 2023 | 9310 | 1.270 |
Why?
|
Turbinates | 6 | 2019 | 65 | 1.250 |
Why?
|
Nasal Mucosa | 8 | 2012 | 415 | 1.160 |
Why?
|
Exophthalmos | 5 | 2014 | 97 | 0.950 |
Why?
|
Nasolacrimal Duct | 4 | 2020 | 79 | 0.950 |
Why?
|
Tissue Adhesions | 6 | 2019 | 218 | 0.940 |
Why?
|
Cell Adhesion Molecules | 4 | 2019 | 1602 | 0.900 |
Why?
|
Decision Trees | 5 | 2020 | 504 | 0.870 |
Why?
|
Quality of Life | 16 | 2023 | 13359 | 0.850 |
Why?
|
Tears | 1 | 2024 | 251 | 0.810 |
Why?
|
Reoperation | 12 | 2019 | 4300 | 0.710 |
Why?
|
Hemangioma, Cavernous | 3 | 2019 | 107 | 0.710 |
Why?
|
Psychotherapeutic Processes | 1 | 2020 | 51 | 0.700 |
Why?
|
Dilatation | 2 | 2020 | 306 | 0.700 |
Why?
|
Dacryocystitis | 1 | 2020 | 68 | 0.690 |
Why?
|
Sphenoid Bone | 4 | 2010 | 177 | 0.660 |
Why?
|
Sensory Thresholds | 1 | 2020 | 377 | 0.640 |
Why?
|
Orbital Neoplasms | 3 | 2019 | 222 | 0.630 |
Why?
|
Debridement | 2 | 2014 | 493 | 0.610 |
Why?
|
Graves Disease | 6 | 2010 | 238 | 0.600 |
Why?
|
Otolaryngology | 4 | 2015 | 693 | 0.600 |
Why?
|
Surgery, Computer-Assisted | 6 | 2008 | 1002 | 0.590 |
Why?
|
Postoperative Complications | 23 | 2019 | 15609 | 0.590 |
Why?
|
Olfaction Disorders | 1 | 2020 | 224 | 0.590 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2014 | 474 | 0.580 |
Why?
|
Ethmoid Sinusitis | 3 | 2011 | 25 | 0.570 |
Why?
|
Eye Neoplasms | 1 | 2019 | 307 | 0.560 |
Why?
|
Osteotomy | 5 | 2013 | 836 | 0.560 |
Why?
|
Eustachian Tube | 3 | 2007 | 99 | 0.560 |
Why?
|
Treatment Outcome | 38 | 2024 | 64572 | 0.560 |
Why?
|
Granuloma | 1 | 2019 | 327 | 0.550 |
Why?
|
Optic Nerve Diseases | 4 | 2009 | 342 | 0.530 |
Why?
|
Drug-Eluting Stents | 2 | 2020 | 681 | 0.520 |
Why?
|
Cost-Benefit Analysis | 6 | 2020 | 5493 | 0.520 |
Why?
|
Sphenoid Sinusitis | 2 | 2010 | 10 | 0.500 |
Why?
|
Psychometrics | 3 | 2024 | 3062 | 0.500 |
Why?
|
Speech | 2 | 2017 | 555 | 0.500 |
Why?
|
Rhinoplasty | 1 | 2019 | 238 | 0.490 |
Why?
|
Lacrimal Apparatus | 1 | 2017 | 223 | 0.490 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 2 | 2012 | 87 | 0.480 |
Why?
|
Mucocele | 2 | 2013 | 51 | 0.460 |
Why?
|
Ethmoid Sinus | 4 | 2011 | 57 | 0.450 |
Why?
|
Middle Aged | 77 | 2024 | 220603 | 0.450 |
Why?
|
Postoperative Care | 3 | 2019 | 1467 | 0.450 |
Why?
|
Laryngoscopy | 2 | 2016 | 707 | 0.430 |
Why?
|
Optic Nerve | 2 | 2007 | 572 | 0.430 |
Why?
|
Diplopia | 5 | 2016 | 214 | 0.430 |
Why?
|
Conflict of Interest | 1 | 2018 | 554 | 0.430 |
Why?
|
Maxillary Sinus | 1 | 2014 | 180 | 0.430 |
Why?
|
Ethmoid Bone | 5 | 2009 | 35 | 0.420 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2015 | 242 | 0.410 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2012 | 74 | 0.410 |
Why?
|
Humans | 131 | 2024 | 760740 | 0.400 |
Why?
|
Prospective Studies | 27 | 2023 | 54364 | 0.390 |
Why?
|
Choline O-Acetyltransferase | 1 | 2012 | 156 | 0.390 |
Why?
|
Male | 88 | 2024 | 360402 | 0.390 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2008 | 8998 | 0.380 |
Why?
|
Female | 86 | 2024 | 392203 | 0.370 |
Why?
|
Adult | 67 | 2024 | 220995 | 0.370 |
Why?
|
Laser Therapy | 5 | 2007 | 1093 | 0.370 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39062 | 0.360 |
Why?
|
Skull Base | 2 | 2012 | 292 | 0.360 |
Why?
|
Quality-Adjusted Life Years | 5 | 2020 | 1723 | 0.360 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 825 | 0.350 |
Why?
|
Facial Nerve | 7 | 1993 | 277 | 0.340 |
Why?
|
Asthma | 6 | 2017 | 6234 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 23 | 2014 | 20556 | 0.340 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1040 | 0.340 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1517 | 0.330 |
Why?
|
Models, Economic | 4 | 2017 | 714 | 0.330 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.330 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1810 | 0.320 |
Why?
|
Aged | 50 | 2024 | 169092 | 0.320 |
Why?
|
Markov Chains | 3 | 2017 | 965 | 0.320 |
Why?
|
Otitis Media with Effusion | 2 | 2007 | 115 | 0.300 |
Why?
|
Free Tissue Flaps | 1 | 2012 | 331 | 0.300 |
Why?
|
Epistaxis | 4 | 2013 | 112 | 0.290 |
Why?
|
Frontal Bone | 1 | 2007 | 105 | 0.290 |
Why?
|
Retrospective Studies | 26 | 2020 | 80583 | 0.280 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 704 | 0.280 |
Why?
|
Faculty, Medical | 1 | 2015 | 1204 | 0.280 |
Why?
|
Medicare | 3 | 2024 | 6774 | 0.270 |
Why?
|
Eosinophilia | 3 | 2003 | 559 | 0.260 |
Why?
|
Ear Diseases | 2 | 2007 | 180 | 0.260 |
Why?
|
Imaging, Three-Dimensional | 3 | 2008 | 4058 | 0.240 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2007 | 354 | 0.230 |
Why?
|
Sickness Impact Profile | 3 | 2005 | 299 | 0.230 |
Why?
|
Optics and Photonics | 3 | 2000 | 306 | 0.230 |
Why?
|
Ointment Bases | 1 | 2003 | 3 | 0.220 |
Why?
|
Tampons, Surgical | 1 | 2003 | 10 | 0.220 |
Why?
|
Nasal Cavity | 3 | 2015 | 304 | 0.220 |
Why?
|
Osteoma | 1 | 2003 | 12 | 0.220 |
Why?
|
Intraoperative Complications | 4 | 2013 | 1161 | 0.210 |
Why?
|
Foreign-Body Reaction | 1 | 2003 | 157 | 0.210 |
Why?
|
Drug Hypersensitivity | 2 | 2009 | 917 | 0.200 |
Why?
|
Age Factors | 2 | 2018 | 18381 | 0.200 |
Why?
|
Skull Neoplasms | 1 | 2003 | 173 | 0.200 |
Why?
|
Software | 2 | 2014 | 4432 | 0.200 |
Why?
|
Microsurgery | 1 | 2007 | 793 | 0.190 |
Why?
|
Fibroma | 1 | 2003 | 190 | 0.190 |
Why?
|
Mitomycin | 1 | 2002 | 263 | 0.190 |
Why?
|
Neural Pathways | 1 | 2012 | 3056 | 0.190 |
Why?
|
Aged, 80 and over | 20 | 2018 | 58919 | 0.180 |
Why?
|
Visual Acuity | 4 | 2016 | 2676 | 0.170 |
Why?
|
Intraoperative Care | 2 | 2004 | 767 | 0.170 |
Why?
|
Aspirin | 2 | 2009 | 3127 | 0.170 |
Why?
|
Intraoperative Period | 2 | 2019 | 510 | 0.170 |
Why?
|
Nerve Compression Syndromes | 2 | 2014 | 160 | 0.160 |
Why?
|
Cohort Studies | 9 | 2021 | 41464 | 0.160 |
Why?
|
Gene Expression Profiling | 3 | 2011 | 9417 | 0.160 |
Why?
|
Time Factors | 7 | 2023 | 39908 | 0.150 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2002 | 678 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2270 | 0.150 |
Why?
|
Smell | 1 | 2020 | 259 | 0.150 |
Why?
|
Fistula | 2 | 1992 | 212 | 0.150 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3451 | 0.140 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2756 | 0.140 |
Why?
|
Treatment Failure | 2 | 2017 | 2635 | 0.140 |
Why?
|
Hemangiopericytoma | 1 | 1997 | 71 | 0.140 |
Why?
|
Adenoidectomy | 1 | 2018 | 167 | 0.140 |
Why?
|
Activities of Daily Living | 3 | 2014 | 2419 | 0.140 |
Why?
|
Nasal Obstruction | 1 | 2019 | 160 | 0.140 |
Why?
|
Eosinophils | 1 | 2001 | 953 | 0.130 |
Why?
|
Absorbable Implants | 1 | 2019 | 338 | 0.130 |
Why?
|
Maxillary Artery | 2 | 1988 | 18 | 0.130 |
Why?
|
Intubation | 2 | 2013 | 139 | 0.130 |
Why?
|
Papilloma, Inverted | 1 | 2015 | 19 | 0.130 |
Why?
|
History, 20th Century | 3 | 2015 | 2764 | 0.130 |
Why?
|
Video-Assisted Surgery | 2 | 2007 | 51 | 0.130 |
Why?
|
Radiology, Interventional | 1 | 1999 | 476 | 0.120 |
Why?
|
Tonsillectomy | 1 | 2018 | 278 | 0.120 |
Why?
|
Health Care Costs | 2 | 2019 | 3238 | 0.120 |
Why?
|
Hypertrophy | 2 | 2007 | 560 | 0.120 |
Why?
|
Adolescent | 19 | 2018 | 88247 | 0.110 |
Why?
|
Palliative Care | 1 | 2009 | 3593 | 0.110 |
Why?
|
Mucous Membrane | 2 | 2007 | 659 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 1995 | 277 | 0.110 |
Why?
|
Ligation | 3 | 2013 | 446 | 0.110 |
Why?
|
Private Practice | 1 | 2014 | 153 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20077 | 0.100 |
Why?
|
Reimbursement Mechanisms | 1 | 2018 | 667 | 0.100 |
Why?
|
Salivary Gland Fistula | 1 | 1992 | 1 | 0.100 |
Why?
|
Biological Products | 1 | 2022 | 912 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1009 | 0.100 |
Why?
|
Palate, Hard | 1 | 2012 | 58 | 0.100 |
Why?
|
Eyelid Diseases | 1 | 2014 | 157 | 0.100 |
Why?
|
Hospitals, University | 1 | 2014 | 565 | 0.100 |
Why?
|
Curettage | 2 | 2007 | 74 | 0.100 |
Why?
|
Health Status | 4 | 2000 | 4076 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 991 | 0.100 |
Why?
|
Therapeutic Irrigation | 1 | 2013 | 289 | 0.100 |
Why?
|
Dissection | 2 | 2009 | 297 | 0.100 |
Why?
|
Barium Sulfate | 1 | 1992 | 180 | 0.100 |
Why?
|
Receptors, Thyrotropin | 1 | 2010 | 45 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1878 | 0.090 |
Why?
|
Pharyngeal Diseases | 1 | 1992 | 134 | 0.090 |
Why?
|
Young Adult | 6 | 2018 | 59191 | 0.090 |
Why?
|
Otitis Media, Suppurative | 1 | 1990 | 27 | 0.090 |
Why?
|
Nasopharyngeal Diseases | 1 | 1990 | 26 | 0.090 |
Why?
|
Dental Implantation, Endosseous | 1 | 2014 | 530 | 0.090 |
Why?
|
Consensus | 2 | 2021 | 3117 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12043 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3798 | 0.090 |
Why?
|
Nose Neoplasms | 1 | 2012 | 249 | 0.090 |
Why?
|
Laryngectomy | 1 | 1992 | 243 | 0.090 |
Why?
|
Adipokines | 2 | 2011 | 308 | 0.080 |
Why?
|
Recovery of Function | 1 | 2020 | 2977 | 0.080 |
Why?
|
Video Recording | 2 | 1992 | 965 | 0.080 |
Why?
|
Incidence | 4 | 2020 | 21339 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2009 | 7403 | 0.080 |
Why?
|
United States | 5 | 2024 | 72292 | 0.080 |
Why?
|
Seasons | 1 | 2015 | 1518 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 9277 | 0.080 |
Why?
|
Enophthalmos | 1 | 2008 | 34 | 0.080 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2008 | 59 | 0.080 |
Why?
|
Cost of Illness | 1 | 1998 | 1937 | 0.070 |
Why?
|
Electromagnetic Phenomena | 2 | 1999 | 160 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2011 | 571 | 0.070 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.070 |
Why?
|
Facial Paralysis | 2 | 2001 | 346 | 0.070 |
Why?
|
Data Collection | 2 | 2014 | 3316 | 0.070 |
Why?
|
Otitis Media | 1 | 1990 | 286 | 0.070 |
Why?
|
Magnetics | 1 | 1991 | 597 | 0.070 |
Why?
|
Drainage | 4 | 2004 | 1156 | 0.070 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2008 | 86 | 0.070 |
Why?
|
Surgery, Plastic | 1 | 1994 | 641 | 0.070 |
Why?
|
Blood Loss, Surgical | 2 | 2005 | 636 | 0.070 |
Why?
|
Eye Diseases | 1 | 2013 | 653 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2008 | 367 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11069 | 0.070 |
Why?
|
Optic Neuritis | 1 | 2008 | 174 | 0.070 |
Why?
|
Palate | 1 | 2007 | 125 | 0.070 |
Why?
|
Chyle | 1 | 1986 | 19 | 0.070 |
Why?
|
Omeprazole | 1 | 2007 | 105 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2008 | 399 | 0.070 |
Why?
|
Audiometry, Pure-Tone | 1 | 2007 | 210 | 0.070 |
Why?
|
Autoantigens | 1 | 2010 | 888 | 0.070 |
Why?
|
Membrane Transport Proteins | 2 | 2011 | 1034 | 0.070 |
Why?
|
Anti-Ulcer Agents | 1 | 2007 | 112 | 0.070 |
Why?
|
Sclerosing Solutions | 1 | 1986 | 79 | 0.070 |
Why?
|
Methods | 3 | 1995 | 1065 | 0.070 |
Why?
|
Endoscopes | 1 | 2007 | 168 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 638 | 0.060 |
Why?
|
Pseudomonas Infections | 1 | 1990 | 621 | 0.060 |
Why?
|
Tetracycline | 1 | 1986 | 216 | 0.060 |
Why?
|
Phenotype | 2 | 2017 | 16572 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3527 | 0.060 |
Why?
|
Tympanic Membrane | 1 | 2007 | 232 | 0.060 |
Why?
|
Respiratory Hypersensitivity | 1 | 2007 | 274 | 0.060 |
Why?
|
Electrophysiology | 1 | 1988 | 1262 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4569 | 0.060 |
Why?
|
Neck Dissection | 1 | 1986 | 201 | 0.060 |
Why?
|
Down-Regulation | 2 | 2011 | 2916 | 0.060 |
Why?
|
Clinical Competence | 1 | 2000 | 4790 | 0.060 |
Why?
|
Arteries | 2 | 2007 | 1120 | 0.060 |
Why?
|
Glycoproteins | 2 | 2011 | 2200 | 0.060 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 1985 | 246 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11118 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3680 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15829 | 0.060 |
Why?
|
Reference Values | 1 | 2010 | 4919 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14024 | 0.050 |
Why?
|
Skin Diseases | 1 | 1992 | 1094 | 0.050 |
Why?
|
Corneal Diseases | 1 | 2009 | 542 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1932 | 0.050 |
Why?
|
Hearing | 1 | 2007 | 501 | 0.050 |
Why?
|
Hemostasis, Surgical | 1 | 2003 | 126 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2003 | 269 | 0.050 |
Why?
|
Vacuoles | 1 | 2003 | 228 | 0.050 |
Why?
|
Physicians | 1 | 2000 | 4583 | 0.050 |
Why?
|
Facial Pain | 1 | 2003 | 120 | 0.050 |
Why?
|
Evoked Potentials | 1 | 1988 | 1047 | 0.050 |
Why?
|
Proton Pump Inhibitors | 1 | 2007 | 533 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2004 | 22153 | 0.050 |
Why?
|
Stents | 1 | 2013 | 3177 | 0.050 |
Why?
|
Otologic Surgical Procedures | 1 | 2003 | 150 | 0.050 |
Why?
|
Vision Disorders | 1 | 2008 | 1088 | 0.050 |
Why?
|
Sarcoma | 1 | 2012 | 1800 | 0.050 |
Why?
|
Metaproterenol | 1 | 1980 | 3 | 0.050 |
Why?
|
Decision Making | 1 | 2014 | 3919 | 0.050 |
Why?
|
Aminophylline | 1 | 1980 | 41 | 0.040 |
Why?
|
Carotid Body Tumor | 1 | 1980 | 34 | 0.040 |
Why?
|
Computer Simulation | 1 | 2014 | 6233 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 1988 | 1780 | 0.040 |
Why?
|
Eye Infections | 1 | 2000 | 62 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4611 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2007 | 821 | 0.040 |
Why?
|
Recurrence | 4 | 2008 | 8426 | 0.040 |
Why?
|
Glaucoma | 1 | 2008 | 1186 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2011 | 4937 | 0.040 |
Why?
|
Arkansas | 1 | 2018 | 59 | 0.040 |
Why?
|
Paraganglioma | 1 | 1980 | 142 | 0.040 |
Why?
|
Facial Muscles | 2 | 1991 | 159 | 0.040 |
Why?
|
Gene Expression | 1 | 2011 | 7569 | 0.040 |
Why?
|
Orbital Diseases | 1 | 2000 | 178 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2001 | 915 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2851 | 0.040 |
Why?
|
Postoperative Period | 2 | 2005 | 1812 | 0.040 |
Why?
|
Parotid Neoplasms | 2 | 1991 | 157 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2001 | 1597 | 0.040 |
Why?
|
Social Adjustment | 1 | 2000 | 632 | 0.040 |
Why?
|
Patient Selection | 2 | 2009 | 4237 | 0.030 |
Why?
|
Kartagener Syndrome | 1 | 1997 | 33 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2005 | 1670 | 0.030 |
Why?
|
Speech Acoustics | 1 | 1997 | 154 | 0.030 |
Why?
|
Absenteeism | 1 | 1998 | 247 | 0.030 |
Why?
|
Head and Neck Neoplasms | 2 | 1988 | 2894 | 0.030 |
Why?
|
Therapy, Computer-Assisted | 1 | 1998 | 266 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14649 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 846 | 0.030 |
Why?
|
Headache | 1 | 2003 | 1255 | 0.030 |
Why?
|
Risk Factors | 3 | 2016 | 74128 | 0.030 |
Why?
|
Holmium | 1 | 1994 | 29 | 0.030 |
Why?
|
Ischemia | 1 | 1983 | 1885 | 0.030 |
Why?
|
Yttrium | 1 | 1994 | 33 | 0.030 |
Why?
|
Electric Stimulation | 2 | 1991 | 1734 | 0.030 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2015 | 184 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1663 | 0.030 |
Why?
|
Sphenoid Sinus | 1 | 1994 | 99 | 0.030 |
Why?
|
Work | 1 | 1995 | 195 | 0.030 |
Why?
|
Monitoring, Intraoperative | 1 | 2000 | 941 | 0.030 |
Why?
|
Office Visits | 1 | 1998 | 593 | 0.030 |
Why?
|
Ohio | 1 | 1994 | 322 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2001 | 1835 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 1983 | 1418 | 0.030 |
Why?
|
Blepharospasm | 1 | 1993 | 29 | 0.030 |
Why?
|
Cautery | 1 | 2013 | 71 | 0.030 |
Why?
|
Proteus Infections | 1 | 1992 | 10 | 0.030 |
Why?
|
Pain | 2 | 2000 | 5062 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2000 | 1438 | 0.030 |
Why?
|
Vision, Ocular | 1 | 1995 | 454 | 0.030 |
Why?
|
Oculomotor Muscles | 1 | 1996 | 406 | 0.020 |
Why?
|
Single-Blind Method | 1 | 1996 | 1575 | 0.020 |
Why?
|
Action Potentials | 2 | 1991 | 1825 | 0.020 |
Why?
|
Strabismus | 1 | 1996 | 317 | 0.020 |
Why?
|
Edema | 1 | 1996 | 765 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6961 | 0.020 |
Why?
|
Surgical Instruments | 1 | 1994 | 383 | 0.020 |
Why?
|
Bandages | 1 | 2013 | 269 | 0.020 |
Why?
|
Necrosis | 1 | 1996 | 1610 | 0.020 |
Why?
|
Botulinum Toxins | 1 | 1993 | 189 | 0.020 |
Why?
|
Silicone Elastomers | 1 | 1991 | 78 | 0.020 |
Why?
|
Observer Variation | 1 | 1997 | 2607 | 0.020 |
Why?
|
Maxilla | 1 | 1994 | 494 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1997 | 2358 | 0.020 |
Why?
|
Adenoma, Pleomorphic | 1 | 1991 | 75 | 0.020 |
Why?
|
Acute Disease | 2 | 2016 | 7236 | 0.020 |
Why?
|
Nose | 1 | 1994 | 521 | 0.020 |
Why?
|
Nose Diseases | 1 | 1991 | 79 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2011 | 326 | 0.020 |
Why?
|
Nasal Septum | 1 | 1991 | 130 | 0.020 |
Why?
|
Boston | 1 | 2003 | 9313 | 0.020 |
Why?
|
Drug Costs | 1 | 1998 | 1183 | 0.020 |
Why?
|
Carotid Artery, External | 1 | 1989 | 37 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1624 | 0.020 |
Why?
|
Rhabdomyosarcoma | 1 | 2012 | 358 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2363 | 0.020 |
Why?
|
Sarcoma, Kaposi | 1 | 2012 | 374 | 0.020 |
Why?
|
Self Concept | 1 | 1995 | 1046 | 0.020 |
Why?
|
Laryngeal Diseases | 1 | 1992 | 243 | 0.020 |
Why?
|
Immunocompetence | 1 | 2008 | 138 | 0.020 |
Why?
|
Child | 5 | 2016 | 80089 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1995 | 1173 | 0.020 |
Why?
|
Voice Disorders | 1 | 1992 | 284 | 0.020 |
Why?
|
Emotions | 1 | 2000 | 2741 | 0.020 |
Why?
|
SEER Program | 1 | 2012 | 1450 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 2278 | 0.020 |
Why?
|
Catheterization | 1 | 1992 | 1428 | 0.020 |
Why?
|
Cats | 1 | 1988 | 974 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2872 | 0.020 |
Why?
|
Prognosis | 4 | 2012 | 29601 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2011 | 1130 | 0.020 |
Why?
|
Linear Models | 1 | 1996 | 5866 | 0.020 |
Why?
|
Mycoses | 1 | 2008 | 386 | 0.020 |
Why?
|
Mental Health | 1 | 2000 | 3253 | 0.020 |
Why?
|
Health Surveys | 1 | 1995 | 4036 | 0.020 |
Why?
|
Wound Healing | 1 | 1996 | 2802 | 0.010 |
Why?
|
Reaction Time | 1 | 1991 | 2087 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5034 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1992 | 1406 | 0.010 |
Why?
|
Acoustic Impedance Tests | 1 | 2003 | 110 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8835 | 0.010 |
Why?
|
Radiotherapy | 1 | 1989 | 1497 | 0.010 |
Why?
|
Middle Ear Ventilation | 1 | 2003 | 101 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4117 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6074 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1989 | 1189 | 0.010 |
Why?
|
Dogs | 1 | 1985 | 3837 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1992 | 2768 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 42193 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 1991 | 8516 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2242 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10072 | 0.010 |
Why?
|
Focus Groups | 1 | 2005 | 1409 | 0.010 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 1984 | 536 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4408 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10549 | 0.010 |
Why?
|
Cellulitis | 1 | 2000 | 209 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7583 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7963 | 0.010 |
Why?
|
Abscess | 1 | 2000 | 606 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 2 | 1989 | 4021 | 0.010 |
Why?
|
Length of Stay | 1 | 1988 | 6418 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12966 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1997 | 2561 | 0.010 |
Why?
|
Cilia | 1 | 1997 | 492 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 5239 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1980 | 6305 | 0.010 |
Why?
|
Vasa Vasorum | 1 | 1989 | 25 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1986 | 6345 | 0.000 |
Why?
|
Primary Health Care | 1 | 2005 | 4677 | 0.000 |
Why?
|
Rupture | 1 | 1989 | 443 | 0.000 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1989 | 880 | 0.000 |
Why?
|
Nerve Regeneration | 1 | 1993 | 796 | 0.000 |
Why?
|
Animals | 2 | 1988 | 168202 | 0.000 |
Why?
|
Oropharyngeal Neoplasms | 1 | 1989 | 491 | 0.000 |
Why?
|
Pharyngitis | 1 | 1984 | 220 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36401 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1993 | 10754 | 0.000 |
Why?
|